La vasopressine chez le patient en état critique [Vasopressin in the critically ill patient]

Details

Serval ID
serval:BIB_11E441D6377E
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
La vasopressine chez le patient en état critique [Vasopressin in the critically ill patient]
Journal
Revue medicale suisse
Author(s)
Cuda L., Liaudet L., Ben-Hamouda N.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
01/04/2020
Peer-reviewed
Oui
Volume
16
Number
688
Pages
652-656
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
Vasopressin (AVP) is a posterior pituitary hormone initially known for its antidiuretic actions. In this article, we recall the biochemical and pharmacological characteristics of the AVP and its analogues. Currently, its main indication in critical care medicine is vasoplegic shock in view of its vasopressive properties. This strong vasopressive activity is related to the activation of V1 receptors located in the vascular smooth muscle. The scientific evidence of the AVP therapy, and its potential benefits versus norepinephrine in vasoplegic shock, is reviewed in this article. Similarly, we present the other indications of vasopressin in the critical patient, based on recent studies and international guidelines.
Pubmed
Create date
23/09/2019 11:31
Last modification date
05/04/2020 6:20
Usage data